| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|---|
| Revenues | 778 | 504* | 81 | 11* |
| Cost of sales | 635 | 417* | 64 | NaN |
| Research and development | NaN | 833* | 5 | 1,663* |
| General and administrative | 389 | 4,710* | 1,004 | 1,348* |
| Total operating expenses | 1,024 | 5,960* | 1,073 | 3,011* |
| Operating loss | -246 | -5,456* | -992 | -3,000* |
| Foreign exchange gains (losses) | 39 | 115* | -14 | -13* |
| Interest income (expense) | 9 | 35* | 9 | NaN |
| Interest income | NaN | NaN | NaN | 3* |
| Gain on deconsolidation of former subsidiary | NaN | 4,947* | NaN | NaN |
| Other income, net | 31 | 327* | 9 | 13* |
| Total other income, net | 79 | 5,424* | 4 | 3* |
| Loss from continuing operations before taxes | -167 | -32* | -988 | -2,998* |
| Income tax provision | 30 | 2* | NaN | -195* |
| Net loss from continuing operations | -197 | NaN | NaN | NaN |
| Net loss | -197 | -34* | -988 | -2,803 |
| Dividend on convertible exchangeable preferred shares | 20 | -2* | 21 | NaN |
| Deemed dividend on warrant exchange | NaN | -6,551* | -1,494 | NaN |
| Net loss applicable to common shareholders | -217 | -6,583 | -2,503 | -2,803 |
| Basic EPS | NaN | -2.679 | -1.31 | -0.126 |
| Diluted EPS | NaN | -2.679 | -1.31 | -0.126 |
| Basic Average Shares | 5,458,564 | 2,457,655 | 1,912,495 | 22,314,000 |
| Diluted Average Shares | 5,458,564 | 2,457,655 | 1,912,495 | 22,314,000 |
Bio Green Med Solution, Inc. (BGMS)
Bio Green Med Solution, Inc. (BGMS)